CUSIP: 29970R105
What is CUSIP 29970R105?
CUSIP 29970R105 identifies EVAX - EVAXION BIOTECH A S - ADS in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 29970R105:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q1 | 0 | $0 | -$307,330 | 0 | |
| 2023 Q4 | 437,168 | $307,330 | -$33,919 | $0.69 | 8 |
| 2023 Q3 | 133,705 | $115,861 | -$25,462 | $0.86 | 10 |
| 2023 Q2 | 161,337 | $209,754 | -$118,299 | $1.30 | 9 |
| 2023 Q1 | 258,202 | $291,368 | +$204,804 | $1.13 | 9 |
| 2022 Q4 | 92,896 | $166,926 | -$92,369 | $1.80 | 8 |
| 2022 Q3 | 143,252 | $377,000 | -$207,418 | $2.63 | 5 |
| 2022 Q2 | 226,325 | $441,000 | -$1,402,037 | $1.95 | 7 |
| 2022 Q1 | 678,270 | $2,060,000 | -$1,258,575 | $3.05 | 11 |
| 2021 Q4 | 1,077,414 | $4,763,000 | +$1,884,508 | $4.42 | 11 |
| 2021 Q3 | 340,282 | $3,279,000 | -$733,210 | $9.65 | 7 |
| 2021 Q2 | 439,553 | $3,330,000 | -$2,860,629 | $7.67 | 6 |
| 2021 Q1 | 883,883 | $5,119,000 | +$5,119,000 | $5.90 | 9 |